Lacosamide Oral Solution
Drug Details
- Generic Name
- Lacosamide Oral Solution
- Brand Names
- Lacosamide Oral Solution
- Application Number
- ANDA214672
- Sponsor
- Ascend Laboratories, LLC
- NDC Codes
- 1
- Dosage Forms
- SOLUTION
- Routes
- ORAL
- Active Ingredients
- LACOSAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Lacosamide oral solution is indicated for: Treatment of partial-onset seizures in patients 4 years of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide oral solution is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide oral solution is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older. Additional pediatric use information is approved for UCB, Inc.’s VIMPAT ® (lacosamide) oral solution. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.